SCHEMBL16758097

SCHEMBL16758097

COC(=O)c1ccc(-c2ccc(OCC3CCN(CC4(C(F)(F)F)CCC4)CC3)cn2)cc1F

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 7/20 0.53
WNT1 P04628 2/20 0.40
GSK3B P49841 2/20 0.40
DYRK1A Q13627 2/20 0.40
CYP4F2 P78329 3/20 0.40
CYP4A11 Q02928 3/20 0.40
CHRM2 P08172 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
SCN9A Q15858 2/20 0.37
PARP10 Q53GL7 2/20 0.37
PARP15 Q460N3 1/20 0.37
HPGDS O60760 1/20 0.36
SCN7A Q01118 1/20 0.36
SCN5A Q14524 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16769052 0.91 GPR119 (0.51) GPR119WNT1GSK3BDYRK1ACYP4F2
SCHEMBL15538441 0.90 CHRM2 (0.44) GPR119WNT1GSK3BDYRK1ACHRM2
SCHEMBL18848890 0.88 GPR119 (0.49) GPR119WNT1GSK3BDYRK1A
SCHEMBL18818387 0.87 GPR119 (0.47) GPR119WNT1GSK3BDYRK1ACYP4F2
SCHEMBL21043193 0.87 GPR119 (0.49) GPR119WNT1GSK3BDYRK1ACYP4F2
SCHEMBL21042994 0.87 GPR119 (0.48) GPR119WNT1GSK3BDYRK1ACYP4F2
SCHEMBL18848990 0.86 GPR119 (0.51) GPR119CYP4F2CYP4A11
SCHEMBL16757807 0.86 GPR119 (0.48) GPR119WNT1GSK3BDYRK1ACYP4F2
SCHEMBL16757803 0.86 GPR119 (0.48) GPR119WNT1GSK3BDYRK1ACYP4F2
SCHEMBL16769044 0.86 GPR119 (0.47) GPR119WNT1GSK3BDYRK1ACYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3074384-B1 AMIDE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-05-22 EP disclosed
US-9776987-B2 Amide derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2017-10-03 US disclosed
US-20170129875-A1 AMIDE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2017-05-11 US disclosed
EP-3074384-A1 AMIDE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2016-10-05 EP disclosed
WO-2015080446-A1 AMIDE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170129875-A1 AMIDE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GLP1R GPR119 1/4885WNT1 3863/4885GSK3B 3922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.